Thursday 21 May 2026

One To Watch

Cobrek Pharmaceuticals

Company Overview

Want to Update your Company's Profile?


Latest Cobrek Pharmaceuticals News

Perrigo buys full control of Cobrek Pharma for about $45 million
31 December 2012
More Cobrek Pharmaceuticals news >


Today's issue

MHRA proposes new framework to accelerate rare disease therapies in UK
Pharmaceutical
MHRA proposes new framework to accelerate rare disease therapies in UK
21 May 2026
Biotechnology
Scene set for Scenic to take ‘top-notch science’ into the clinic
20 May 2026
Pharmaceutical
US State price-setting boards create more questions than answers
20 May 2026
Pharmaceutical
Chiesi appoints Maria Paola Chiesi as first female chair
20 May 2026
Biotechnology
UK launches national framework to strengthen advanced therapy clinical trials
20 May 2026
Pharmaceutical
Remepy posts strong Phase IIa results for Hybridopa
20 May 2026
Pharmaceutical
Pfizer advances pediatric pneumococcal vaccine program
20 May 2026




Copyright © The Pharma Letter 2026

 |  Headless Content Management with Blaze